Cargando…
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
BACKGROUND: Disease modifying anti-rheumatic drugs (DMARDs) may interfere with bone healing. Previous studies give conflicting advice regarding discontinuation of these drugs in the peri-operative setting. No consensus exists in current practice especially with the newer DMARDs such as Leflunomide,...
Autores principales: | Malviya, Ajay, Kuiper, Jan Herman, Makwana, Nilesh, Laing, Patrick, Ashton, Brian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694161/ https://www.ncbi.nlm.nih.gov/pubmed/19470170 http://dx.doi.org/10.1186/1749-799X-4-17 |
Ejemplares similares
-
Mechanical characteristics of three staples commonly used in foot surgery
por: Rethnam, Ulfin, et al.
Publicado: (2009) -
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
por: Krasowski, Matthew D.
Publicado: (2010) -
Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010) -
Drug resistance in leishmaniasis: Newer developments
por: Mohapatra, Sarita
Publicado: (2014) -
Newer drug delivery systems in anesthesia
por: Dave, Sona, et al.
Publicado: (2017)